Actively Recruiting
Safety and Effectiveness Study of Cellbooster Shape Skin Injections for Facial Aging in Adults 35 and Older
Led by Suisselle · Updated on 2026-06-09
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of Cellbooster Shape CBS, a skin injection product designed to reduce signs of facial aging in healthy adults aged 35 and over. CBS uses patented CHAC Technology and contains non-crosslinked hyaluronic acid with L-Carnitine and vitamin C. This investigational product aims to improve skin microcirculation, hydration, volume, and elasticity in areas of facial puffiness and aging. Participants will receive three injection sessions of CBS into the medium and lower face areas over a 28-day period, with injections spaced two weeks apart. A maximum of 9mL of CBS may be injected into up to three puffiness zones such as double chin or malar puffiness. The study is open-label and non-comparative, focusing on treatment effects observed through clinical assessments and participant feedback. Throughout the 70-day study, participants will undergo several objective skin measurements using specialized instruments to assess skin volume, hydration, elasticity, and microcirculation. Clinical and participant evaluations of aesthetic improvement will be recorded at days 42 and 70. Safety monitoring includes tracking injection site reactions and adverse events during and after the treatment sessions to ensure participant well-being.
CONDITIONS
Brief Title
Effectiveness and Safety of Cellbooster Shape in Healthy Subjects
Research Team
N
Nina Nguon, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here